Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
Monday at 6 on WRAL: WRAL investigates why some veterinarians face minor consequences for fatal errors!
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Actinium Pharmaceuticals Inc
(NY:
ATNM
)
1.820
+0.140 (+8.33%)
Streaming Delayed Price
Updated: 2:28 PM EDT, Oct 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
151,214
Open
1.710
Bid (Size)
1.810 (10)
Ask (Size)
1.820 (5)
Prev. Close
1.680
Today's Range
1.710 - 1.830
52wk Range
1.330 - 10.24
Shares Outstanding
21,331,314
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 25, 2024
Via
Benzinga
Actinium Pharmaceuticals, Inc. (ATNM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 18, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Performance
YTD
-65.79%
-65.79%
1 Month
+1.11%
+1.11%
3 Month
-75.00%
-75.00%
6 Month
-75.34%
-75.34%
1 Year
-67.32%
-67.32%
More News
Read More
Actinium Pharmaceuticals, Inc. (ATNM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 09, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
ATNM Investors Have Opportunity to Join Actinium Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
August 07, 2024
From
The Schall Law Firm
Via
Business Wire
ATNM Stock Earnings: Actinium Pharmaceuticals Beats EPS for Q2 2024
August 06, 2024
Via
InvestorPlace
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
August 06, 2024
Via
Benzinga
S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge
August 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Tumbles 950 Points; ISM Services PMI Surges In July
August 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Actinium Pharmaceuticals Receives FDA Request For Additional Studies On Leukemia Treatment
August 05, 2024
Via
Benzinga
Exposures
Product Safety
Nasdaq Tumbles 3%; Tyson Foods Earnings Top Views
August 05, 2024
Via
Benzinga
3 Under-$10 Biotech Stocks That Could Make You Rich
July 11, 2024
Via
InvestorPlace
3 Clinical-Stage Biotech Stocks to Buy for Multibagger Returns
July 02, 2024
Via
InvestorPlace
Treatment of Blood Cancers - Biopharma Companies Building out their Pipeline of Solutions
June 18, 2024
Via
Newsfile
Actinium Presents Exciting Data On Leukemic Cell Killing in Preclinical Acute Myeloid Leukemia Models at the 2024 EHA Congress
June 18, 2024
Via
AB Newswire
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase
June 17, 2024
Via
FinancialNewsMedia
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase
June 17, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
June 17, 2024
Via
FinancialNewsMedia
Biopharma Stocks Quest for Solutions for Acute Myeloid Leukemia (AML)
June 17, 2024
Via
Newsfile
Actinium Presents First Ever Data Demonstrating Statistically Significant Anti-Tumor Control and Potent Leukemic Cell Killing with Actimab-A in Combination with Leading Menin Inhibitors in Preclinical Acute Myeloid Leukemia Models at the 2024 EHA Congress
June 17, 2024
Via
FinancialNewsMedia
Actinium Pharmaceuticals (ATNM) Reveals Promising Results from SIERRA Trial at EHA Congress
June 17, 2024
Via
AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024
June 10, 2024
Via
InvestorPlace
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar
June 07, 2024
Via
InvestorPlace
3 Cheap Biotech Stocks to Buy Now: May 2024
May 14, 2024
Via
InvestorPlace
Exposures
Product Safety
Actinium Pharmaceuticals (ATNM) Poised for Breakout as Analysts Project Significant Upside
May 09, 2024
Via
AB Newswire
Actinium Pharmaceuticals (NYSE: ATNM): A Prime Target in a Wave of Radiopharmaceutical Mergers and Acquisitions
May 08, 2024
Via
AB Newswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.